Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes and moderate or severe renal impairment: observations from the SAVOR-TIMI 53 Trial (Q41634829)
Jump to navigation
Jump to search
scientific article published on 31 December 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes and moderate or severe renal impairment: observations from the SAVOR-TIMI 53 Trial |
scientific article published on 31 December 2014 |
Statements
1 reference
Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes and moderate or severe renal impairment: observations from the SAVOR-TIMI 53 Trial (English)
1 reference
Eugene Braunwald
1 reference
Deepak L Bhatt
1 reference
Ramon Corbalan
1 reference
Darren K McGuire
1 reference
SAVOR-TIMI 53 Steering Committee and Investigators
1 reference
Robert Frederich
1 reference
Benjamin M Scirica
1 reference
Itamar Raz
1 reference
Boaz Hirshberg
1 reference
Matthew A Cavender
1 reference
Ofri Mosenzon
1 reference
Ph Gabriel Steg
1 reference
Jaime A Davidson
1 reference
Jose C Nicolau
1 reference
KyungAh Im
1 reference
Amarachi A Umez-Eronini
1 reference
Ping He
1 reference
Lawrence A Leiter
1 reference
31 December 2014
1 reference
1 reference
Identifiers
1 reference